Retinoic acid sensitizes triple-negative breast cancer cells to tamoxifen treatment

被引：0
|
作者：
Coyle, Krysta M. [1 ]
Dean, Cheryl A. [1 ]
Jo, Diana B. [1 ]
Thomas, Margaret [1 ]
Sultan, Mohammad [1 ]
Marcato, Paola [1 ]
机构：
[1] Dalhousie Univ, Halifax, NS B3H 3J5, Canada
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P1-12-14
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-12-14
引用
收藏
页数：2
相关论文
共 50 条
  • [1] LAPATINIB SENSITIZES TRIPLE-NEGATIVE BREAST CANCER CELLS TO HDAC INHIBITORS
    Chen, Y-J.
    Chien, P-H.
    Huang, W-C.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 34 - 34
  • [2] CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy
    Lemesle, Marine
    Geoffroy, Marine
    Alpy, Fabien
    Tomasetto, Catherine-Laure
    Kuntz, Sandra
    Grillier-Vuissoz, Isabelle
    [J]. CANCERS, 2022, 14 (20)
  • [3] Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
    Liang, Sixian
    Peng, Xun
    Li, Xiaoli
    Yang, Ping
    Xie, Linhao
    Li, Yaochen
    Du, Caiwen
    Zhang, Guojun
    [J]. ONCOTARGET, 2015, 6 (02) : 1020 - 1030
  • [4] Retinoic Acid Receptor Alpha Is a Positive Prognostic Biomarker in Triple-Negative Breast Cancer
    Ogden, Angela
    Green, Andrew
    Aleskandarany, Mohammed A.
    Rakha, Emad
    Ellis, Ian O.
    Ali, Simak
    Li, Xiaoxian
    Krishnamurti, Uma
    Reid, Michelle D.
    Rida, Padmashree C. G.
    Aneja, Ritu
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 62A - 63A
  • [5] Retinoic Acid Receptor Alpha Is a Positive Prognostic Biomarker in Triple-Negative Breast Cancer
    Ogden, Angela
    Green, Andrew
    Aleskandarany, Mohammed A.
    Rakha, Emad
    Ellis, Ian O.
    Ali, Simak
    Li, Xiaoxian
    Krishnamurti, Uma
    Reid, Michelle D.
    Rida, Padmashree C. G.
    Aneja, Ritu
    [J]. MODERN PATHOLOGY, 2016, 29 : 62A - 63A
  • [6] Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
    Zhang, Xia
    Bai, Weijun
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (03) : 655 - 659
  • [7] Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin
    Xia Zhang
    Weijun Bai
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 78 : 655 - 659
  • [8] Treatment Horizons for Triple-negative Breast Cancer
    Yeo, W.
    [J]. HONG KONG JOURNAL OF RADIOLOGY, 2015, 18 (02): : 111 - 118
  • [9] Postneoadjuvant treatment for triple-negative breast cancer
    Trapani, Dario
    Ferraro, Emanuela
    Giugliano, Federica
    Bielo, Luca Boscolo
    Curigliano, Giuseppe
    Burstein, Harold J.
    [J]. CURRENT OPINION IN ONCOLOGY, 2022, 34 (06) : 623 - 634
  • [10] Triple-negative breast cancer: is there a treatment on the horizon?
    Yao, Hui
    He, Guangchun
    Yan, Shichao
    Chen, Chao
    Song, Liujiang
    Rosol, Thomas J.
    Deng, Xiyun
    [J]. ONCOTARGET, 2017, 8 (01) : 1913 - 1924
12345